Diabetes insipidus epidemiology and demographics: Difference between revisions
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The prevalence of diabetes insipidus is estimated to be | The prevalence of diabetes insipidus is estimated to be 3:100,000. The prevalence and incidence of both central and nephrogenic DI does not vary by gender. Similarly, no significant racial predilection in prevalence among ethnic groups have been found. | ||
With both central and nephrogenic DI, inherited causes account for approximately 1-2% of all cases. An incidence of about 1 in 20 million births for nephrogenic DI caused by AQP2 mutations has been documented. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 14:59, 12 July 2017
|
Diabetes insipidus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diabetes insipidus epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Diabetes insipidus epidemiology and demographics |
|
Diabetes insipidus epidemiology and demographics in the news |
|
Risk calculators and risk factors for Diabetes insipidus epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
The prevalence of diabetes insipidus is estimated to be 3:100,000. The prevalence and incidence of both central and nephrogenic DI does not vary by gender. Similarly, no significant racial predilection in prevalence among ethnic groups have been found.
With both central and nephrogenic DI, inherited causes account for approximately 1-2% of all cases. An incidence of about 1 in 20 million births for nephrogenic DI caused by AQP2 mutations has been documented.
Epidemiology and Demographics
Prevalence
Incidence
The incidence of diabetes mellitus is 1 in 20 million births for nephrogenic DI caused by AQP2 mutations.[1]
Case Fatality Rate
Age
Gender
Race
Developed countries
Developing countries
References
- ↑ Eisenberger F, Rassweiler J (1987). "Current status of ESWL in the management of renal calculus disease". Contrib Nephrol. 58: 236–52. PMID 3319404.